Pharmacotherapy of insomnia with ramelteon : safety, efficacy and clinical applications

Abstract: Ramelteon is a tricyclic synthetic analog of melatonin that acts specifically on MT1 and MT2 melatonin receptors. Ramelteon is the first melatonin receptor agonist approved by the Food and Drug Administration (FDA) for the treatment of insomnia characterized by sleep onset difficulties. Ra...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pandi Perumal, Seithikurippu R., Spence, David Warren, Verster, Joris C., Srinivasan, Venkataramanujan, Brown, Gregory M., Cardinali, Daniel Pedro, Hardeland, Rüdiger
Formato: Artículo
Lenguaje:Inglés
Inglés
Publicado: Libertas Academica 2019
Materias:
Acceso en línea:https://repositorio.uca.edu.ar/handle/123456789/1646
Aporte de:

Ejemplares similares